3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(4-morpholin-4-ylcyclohexyl)imidazo[1,2-b]pyridazin-6-amine
C25H28FN9O — CID 66551705
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(4-morpholin-4-ylcyclohexyl)imidazo[1,2-b]pyridazin-6-amine
3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(4-morpholin-4-ylcyclohexyl)imidazo[1,2-b]pyridazin-6-amine (PubChem CID 66551705) has the molecular formula C25H28FN9O and a molecular weight of 489.56 g/mol. Its IUPAC name is 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(4-morpholin-4-ylcyclohexyl)imidazo[1,2-b]pyridazin-6-amine.
Molecular Properties
| Compound Name | 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(4-morpholin-4-ylcyclohexyl)imidazo[1,2-b]pyridazin-6-amine |
|---|---|
| PubChem CID | 66551705 |
| Molecular Formula | C25H28FN9O |
| Molecular Weight | 489.56 g/mol |
| Exact Mass | 489.24 |
| IUPAC Name | 3-[2-[(3-fluoro-2-pyridinyl)amino]pyrimidin-5-yl]-N-(4-morpholin-4-ylcyclohexyl)imidazo[1,2-b]pyridazin-6-amine |
| SMILES | Fc1cccnc1Nc1ncc(-c2cnc3ccc(NC4CCC(N5CCOCC5)CC4)nn23)cn1 |
| InChI | InChI=1S/C25H28FN9O/c26-20-2-1-9-27-24(20)32-25-29-14-17(15-30-25)21-16-28-23-8-7-22(33-35(21)23)31-18-3-5-19(6-4-18)34-10-12-36-13-11-34/h1-2,7-9,14-16,18-19H,3-6,10-13H2,(H,31,33)(H,27,29,30,32) |
| InChIKey | DUFJLIPMQNABSH-UHFFFAOYSA-N |
| XLogP | 3.52 |
| TPSA | 105.39 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.56 |
| LogP ≤ 5 | 3.52 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 66551705 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.